Intera Oncology is a device-drug combo, commercial-stage company. Intera's flagship product, the Intera 3000 Hepatic Artery Infusion (HAI) Pump, is the first FDA-approved implantable pump for HAI therapy in colorectal and cholangiocarcinoma patients.